Primerica reports Q2 adjusted EPS $4.71, consensus $4.47

Reports Q2 revenue $803.4M, consensus $748.89M. The company said, “Second quarter operating results were driven by strong sales of investment products and rising client asset values as well as steady premium growth and the predictable margins of the Term Life business. Investment income benefited from higher yielding investments and growth in the Company’s invested asset portfolio. Results were partially offset by weakness in the Senior Health business. Distribution results were strong during the quarter, driven by recruiting and growth in new life-licensed representatives.”